Format

Send to

Choose Destination
Br J Haematol. 2019 May 21. doi: 10.1111/bjh.15980. [Epub ahead of print]

Aggressive systemic mastocytosis: midostaurin is safe, feasible and associated with durable response post-haploidentical allogeneic stem cell transplant.

Author information

1
Department of Medicine, University of Southern California, Keck School of Medicine of USC, Los Angeles, CA, USA.
2
Department of Pathology, University of California Irvine, Children Hospital of Orange County, Los Angeles, CA, USA.
3
Jane Anne Nohl Division of Hematology and Center for the Study of Blood Diseases, Keck School of Medicine of USC, USC Norris Comprehensive Cancer Center, Los Angeles, CA, USA.
4
Pulmonary, Critical Care, University of Southern California, Keck School of Medicine of USC, Los Angeles, CA, USA.

KEYWORDS:

aggressive systemic mastocytosis; haploidentical haematopoietic stem cell transplant; midostaurin

PMID:
31111479
DOI:
10.1111/bjh.15980

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center